BDSX · Biodesix Inc
Market Cap
$277.97M
Shares
10.55M
The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.
| Type | Filing Date | Period | Open |
|---|---|---|---|
| Investor Event Transcript | 2026-08-12 | 2026-09-30 | |
| 8-K | 2026-08-05 | — | |
| 10-Q | 2026-08-05 | 2026-06-30 | |
| Investor Event Transcript | 2026-06-03 | 2026-06-30 | |
| 8-K | 2026-05-20 | 2026-05-19 | |
| 10-Q | 2026-05-04 | 2026-03-31 | |
| 8-K | 2026-05-04 | — | |
| DEF 14A | 2026-04-09 | 2026-05-19 | |
| 8-K | 2026-02-26 | — | |
| 10-K | 2026-02-26 | 2025-12-31 | |
| 8-K/A | 2026-01-12 | — | |
| 10-Q | 2025-11-03 | 2025-09-30 | |
| 8-K | 2025-11-03 | — | |
| 8-K | 2025-10-01 | 2025-09-26 | |
| 8-K | 2025-09-15 | 2025-09-12 | |
| 8-K | 2025-09-11 | — | |
| 8-K | 2025-08-07 | — | |
| 10-Q | 2025-08-07 | 2025-06-30 | |
| 8-K | 2025-05-21 | 2025-05-20 | |
| 8-K | 2025-05-13 | — | |
| 10-Q | 2025-05-13 | 2025-03-31 | |
| DEF 14A | 2025-04-28 | 2025-05-20 | |
| 8-K | 2025-04-17 | 2025-04-15 | |
| 8-K | 2025-03-28 | 2025-03-24 | |
| 10-K | 2025-03-03 | 2024-12-31 | |
| 8-K | 2025-03-03 | — | |
| 8-K | 2025-01-10 | — | |
| 10-Q | 2024-11-01 | 2024-09-30 | |
| 8-K | 2024-11-01 | — | |
| 8-K | 2024-08-15 | 2024-08-14 | |
| 10-Q | 2024-08-07 | 2024-06-30 | |
| 8-K | 2024-08-07 | — | |
| 8-K | 2024-05-23 | 2024-05-21 | |
| 10-Q | 2024-05-08 | 2024-03-31 | |
| 8-K | 2024-05-08 | — | |
| DEF 14A | 2024-04-26 | 2024-05-21 | |
| 8-K | 2024-04-09 | 2024-04-05 | |
| 10-K | 2024-03-01 | 2023-12-31 | |
| 8-K | 2024-03-01 | — | |
| 8-K | 2023-12-20 | 2023-12-15 | |
| 10-Q | 2023-11-07 | 2023-09-30 | |
| 8-K | 2023-11-07 | — | |
| 10-Q | 2023-08-07 | 2023-06-30 | |
| 8-K | 2023-08-07 | — | |
| 8-K | 2023-07-26 | 2023-07-24 | |
| 8-K | 2023-06-06 | 2023-05-31 | |
| 8-K | 2023-05-25 | 2023-05-23 | |
| 8-K | 2023-05-11 | — | |
| 10-Q | 2023-05-11 | 2023-03-31 | |
| DEF 14A | 2023-04-12 | 2023-05-23 |
Showing 1–50 of 87 filings
Key facts
CIK
1439725
CUSIP
09075X207
13F (30d)
39 filings
39 filers
Visit website
Investor relations